Please try another search
Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company’s lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer’s disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer’s disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer’s disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich’s ataxia; and GBA1 gene replacement to treat parkinson’s disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington’s disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Michael J. Higgins | 62 | 2015 | Independent Chairman of the Board |
Glenn F. Pierce | 68 | 2017 | Independent Director |
James Arthur Geraghty | 70 | 2014 | Independent Director |
Steven E. Hyman | 72 | 2015 | Independent Director |
Alfred W. Sandrock | 66 | 2022 | President, CEO & Director |
Nancy Vitale | 53 | 2020 | Independent Director |
Grace E. Colon | 57 | 2023 | Independent Director |
Catherine J. Mackey | 69 | 2022 | Independent Director |
George A. Scangos | 76 | 2023 | Director |
Phillip D. Zamore | - | - | Founder & Member of Scientific Advisory Board |
Jude Onyia | 60 | 2023 | Director |
Guangping Gao | - | - | Founder & Member of Scientific Advisory Board |
Dinah Sah | 63 | 2014 | Consultant & Member of Scientific Advisory Board |
David R. Liu | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review